Medicinal chemistry

#GPCRs #High throughput screening #Medicinal chemistry #Whitepaper

Whitepaper: Understand GPCR second messenger data analysis

A new Whitepaper is now available from Revvity entitled ‘Guidelines and recommendations for analyzing and interpreting GPCR second messenger data‘. The Whitepaper offers expert guidelines for analysing GPCR second messenger data: Detailed comparison of four data analysis methods Practical case studies for method application Specific insights for high-throughput… Read More

#News

#GPCRs #High throughput screening #Medicinal chemistry

Unlock expert insights on GPCR second messenger data analysis

This Whitepaper offers expert guidelines for analysing GPCR second messenger data: Detailed comparison of four data analysis methods Practical case studies for method application Specific insights for high-throughput screening and medicinal chemistry… Read More

#Resources

Map of Australia
#Drug discovery #MedChem Australia #Medical Research Future Fund #Medicinal chemistry

Drug discovery gets $9.75m boost for MedChem Australia 

The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $9.75 million into establishing MedChem Australia, a new national medicinal chemistry initiative.   MedChem Australia will bring together three medical chemistry groups in Australia from the University of Sydney, Monash University and the Walter and Eliza Hall Institute… Read More

#News

#Artificial intelligence (AI) #Funding #Investment #Medicinal chemistry #Neurology #Oncology #PharmEnable

$7.5M investment to target cancer and neurological diseases

PharmEnable has closed a pre-series A investment round of $7.5 million to develop the next generation of small molecule drugs against disease areas of high clinical need. The funding round was led by MP Healthcare Venture Management (MPH), the venture arm of Mitsubishi Tanabe Pharma Group. There was also participation… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Connected chemistry: Choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Webinar: Choose the right drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

Laboratory technology
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Charles River #Collaboration #DNA technology #High throughput screening #Medicinal chemistry #Partnership #Pioneering Medicines

Partners enter multi-programme drug discovery agreement

Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica.  Through the agreement, Pioneering Medicines will apply Logica across a portfolio of targets with the aim of creating optimised small molecules… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Event: How to choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Learn how to choose the best drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

Biochemists working in the lab
#Drug development #Drug discovery #Drug Discovery Chemistry #Medicinal chemistry #Research & development

CAS and Torx Software partner to streamline chemistry workflows

Torx Software and CAS, a division of the American Chemical Society, have revealed that they will collbaorate to connect CAS SciFinder users through the Torx platform to streamline workflows for discovery chemistry.   CAS SciFinder is designed to provide solutions to challenges encountered in scientific research and discovery,… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

How to choose the most promising drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry

Connected chemistry: How to choose the most promising drug candidates from your hit list

AI and machine learning (AI/ML) methods offer an alluring way to expedite the drug discovery process by delivering a large number of possible new candidates for any given therapeutic area. However, insight from medicinal chemists is still necessary to triage and prioritise the most promising molecules for synthesis, and progress… Read More

Webinar date:
Sponsored by Torx Software
#Webinars

#Drug discovery #Genetic editing #Hit identification #Medicinal chemistry #Podcast

Using biotechnology to maximise drug discovery output – podcast 

The latest free-to-listen DDW podcast episode is titled “Using biotechnology to maximise drug discovery output”. It covers two articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine and has been narrated by DDW’s Megan Thomas.  These articles are titled: “The important integration of medicinal chemistry in Hit-to-Lead… Read More

#News

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Gene therapy #Genomics #High Content Screening #High throughput screening #Immunology / Virology & Vaccines #Lead discovery #Lead optimisation #Mass spectrometry / NMR #Medicinal chemistry #Molecular medicine #Organic chemistry #Pharmokinetics #Precision medicine #RNA #Screening #System biology #Systems biology #Therapeutics #Toxicology

The COVID-19 antiviral race: we’re all in this together

The COVID-19 antiviral race: we're all in this together By Uduak Grace Thomas In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically… Read More

#Covid-19 #Exclusive Content

#Academic #Analysis #Assay development optimisation & technology #Cell culture #Cellular assays #Chemistry #Drug discovery #Drug targets #Genetics / genomes #High Content Screening #High throughput screening #Immunology #Lead discovery #Medicinal chemistry #PCR #Pharmacology #RNA #Screening #Stem cells #System biology

Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data

Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data Sponsored by CisBio The question of choosing which methods to use for analyte quantification (signal vs concentration determination, parameters, and format) continues to generate heated debates and divergent understanding. Today, there is still a communication gap between researchers depending… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Biochemistry #Business #Cell culture #Chemistry #Computational chemistry #Drug development #Drug discovery #Enabling technologies #Lead discovery #Lead optimisation #Medicinal chemistry #System biology

How drug discovery software is inspiring US high-school students

Optibrium and the North Carolina School of Science and Mathematics (NCSSM), are celebrating five years of an education support collaboration. As part of this specialist science and technology summer school initiative, Optibrium provides free access to StarDrop, Optibrium’s software for small molecule design, optimisation and data analysis. This… Read More

#Covid-19 #News